<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/93DDE475-FB43-4828-87EF-E974ED8CF0F4"><gtr:id>93DDE475-FB43-4828-87EF-E974ED8CF0F4</gtr:id><gtr:name>Asterand UK Acquisition Limited</gtr:name><gtr:address><gtr:line1>2A ORCHARD ROAD</gtr:line1><gtr:city>ROYSTON</gtr:city><gtr:postCode>SG8 5HD</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/93DDE475-FB43-4828-87EF-E974ED8CF0F4" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>93DDE475-FB43-4828-87EF-E974ED8CF0F4</gtr:id><gtr:name>Asterand UK Acquisition Limited</gtr:name><gtr:address><gtr:line1>2A ORCHARD ROAD</gtr:line1><gtr:city>ROYSTON</gtr:city><gtr:postCode>SG8 5HD</gtr:postCode><gtr:region>West Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>233711.0</gtr:offerGrant><gtr:projectCost>389516.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>0.0</gtr:offerGrant><gtr:projectCost>112191.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B5E08BCA-4EA2-4C62-BC97-B4E40701315A" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>B5E08BCA-4EA2-4C62-BC97-B4E40701315A</gtr:id><gtr:name>Definigen Limited</gtr:name><gtr:address><gtr:line1>100 HILLS ROAD</gtr:line1><gtr:city>CAMBRIDGE</gtr:city><gtr:postCode>CB2 1PH</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>142043.0</gtr:offerGrant><gtr:projectCost>236737.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/FAF82161-8CA5-46DA-A439-00B26B5A636C"><gtr:id>FAF82161-8CA5-46DA-A439-00B26B5A636C</gtr:id><gtr:firstName>Caroline</gtr:firstName><gtr:surname>Freathy</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=102517"><gtr:id>8B6FB9D5-FC66-43E1-939D-A0E3892777DF</gtr:id><gtr:title>Development of a human 3D in vitro model of pancreatic beta cell health</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>102517</gtr:grantReference><gtr:abstractText>Diabetes is a serious condition where the amount of sugar (glucose) in the blood is too high because the body

either cannot produce enough of the hormone insulin or cannot use the insulin effectively. There is no known

cure for diabetes, and although many treatment options are available, they often do not prevent the disabling

long-term complications of the disease. In the search for new treatments, researchers are now trying to find

drugs that will protect the insulin-producing (beta) cells of the pancreas. To support this research, the aim of

this project is to develop a new 3D human cell-based model of pancreatic beta cell health. The model will be

developed using freshly isolated human islets. The team will then investigate whether a more sustainable

human cell source can be used and whether the model can be miniaturised, so more drugs can be tested in

each assay. If the project is successful, it will enable the faster testing of potential new anti-diabetes drugs, and

ultimately help to identify new and improved treatments for diabetes. If widely adopted, the resulting model

will also reduce the number of animals currently used in diabetes research and drug discovery.</gtr:abstractText><gtr:fund><gtr:end>2018-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2016-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>375754</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">102517</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>